Praesidian Capital Invests $6M To Support Meta Pharma’s Recapitalization

Praesidian Capital LLC of New York invested $6 million in Meta Pharmaceutical Services LLC. The investment took the form of subordinated debt. The investment supports Meta Pharmaceutical’s recapitalization by DFW Capital Partners and management. Meta Pharmaceutical is a Pennsylvania-based company that provide sales and marketing data services.

1 October 2010•3 mins read
Feature image
LinkedInXEmail
LinkedInXEmail